Klinische Studie

AVAVA MIRIA General Use

NCT: NCT06868615 · RECRUITING

NCT-IDNCT06868615

Medizinische Daten: StatusRECRUITING

Startdatum2024-09-11

Abschluss2027-12-30

SponsorAVAVA, Inc. (INDUSTRY)

First posted2025-03-11

Last updated2026-09-15

Kurzzusammenfassung

A general protocol to treat a variety of dermatologic conditions and collect patient feedback. Primary outcome is the collection and analysis of patient questionnaires related to the overall experience of the device treatment. Secondary outcome measures include physician and subject evaluations in regards to improvement seen in the device as well as assessment of side effects.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.